OSCR

RNA targeting therapy for a prenatally enriched potassium channel associated with severe childhood epilepsy and premature death.

Overview

Authors: Sean R. Golinski1, Karla Soriano1, Alex C. Briegel1, Madeline C. Burke1, Sheng Tang1, Gemma L. Carvill1, Emma Sherrill2, Claudia Lentucci2, Timothy W. Yu2, Tojo Nakayama2, Ruilong Hu1, Richard S. Smith1
  1. Northwestern University, Feinberg School of Medicine,Chicago, IL USA
  2. Division of Genetics and Genomics, Boston Children’s Hospital,Boston, MA USA
Institutions: Northwestern University (United States); Boston Children's Hospital (United States)
Journal: Nature communications, volume 17, issue 1, article 5864
Dates: received 18 October 2024; accepted 9 April 2026; published online 29 April 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.1038/s41467-026-72334-7 · PMID 42056090 · PMCID PMC13333874 · OpenAlex W7158780943
Open access: gold, a free copy (OpenAlex)
Status: code verified (how the code is found and verified)
Categories: human (organism), epilepsy (population)
Methods: Statistics, Evoked potentials, Machine learning
Keywords: Target validation, Disease model
MeSH: Epilepsy*, Nerve Tissue Proteins*, Potassium Channels, Sodium-Activated*, Animals, Brain, Female, Humans, Infant, Newborn, Male, Neurons, Oligonucleotides, Antisense (* major topic)
Topic: Ion channel regulation and function (Molecular Biology, Biochemistry, Genetics and Molecular Biology), according to OpenAlex
Citations: not cited yet (Europe PMC); 62 references in the paper

Abstract

Dysfunction of the sodium-activated potassium channel KNa1.1 (encoded by KCNT1) is associated with a severe neurodevelopmental condition characterized by frequent seizures (up to hundreds per day), treatment resistance, and increased mortality during childhood. Yet, recent progress with an RNA therapy targeting KCNT1 offers clinical promise1. We characterize the early developmental onset of KNa1.1 channels in prenatal and neonatal brain tissue, establishing a timeline for pathophysiology and a window for therapeutic intervention. Using patch-clamp electrophysiology, we observe functional prenatal KNa1.1 conductance that is developmentally regulated. In excitatory and inhibitory neurons derived from a child’s induced pluripotent stem cells with a KCNT1 pathogenic variant (p.R474H), we detect gain-of-function K+ currents. We use an antisense oligonucleotide RNA therapy developed for two individuals with the p.R474H variant—which results in dramatic reductions in seizure occurrence and severity1—to profile cellular neurophysiology in patient-derived excitatory and inhibitory neurons. We observe a knockdown of p.R474H gain-of-function K+ currents, resulting in a stimulation-dependent change in spiking output in patient-derived induced excitatory and inhibitory neurons. In mid-gestation primary human neurons, ASO knockdown suppresses current-evoked firing, suggesting a potential early therapeutic target before the onset of infantile encephalopathy.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

No file of the authors' code could be read here: it is described below, and read at its source.

Smith-Lab-Neuro

License: none: the authors keep all their rights
State: the link answers, verified on 30 September 2026
Evidence: the link answers
Software Heritage: not checked
Found in: “Code availability”
Not found: README, license file, CITATION.cff, environment file, tests, continuous integration, documentation
Availability: 1 check, the latest on 30 September 2026: the link answers (HTTP 200)
  • 30 September 2026: the link answers (HTTP 200)

Code availability

See Richard Smith Lab GitHub for Analysis code or access to data. https://github.com/Smith-Lab-Neuro.

Reproduced under the paper's license (CC BY), from the paper cited above.

Tracing map

Proposed by the machine: these links were found in the paper and verified at the source, without human review. The map will receive a Zenodo DOI once one of the paper's authors has validated it with their ORCID.

What the map holds:

  • 1 repository of the authors' code, each at its verified commit, with its license and how the link was found in the paper;
  • 0 scripts, each with its path and the digest of its content;
  • no match between paragraphs and code yet;
  • neither the text of the paper nor the code itself.

Its JSON (tracing-map.json) is deposited on Zenodo with its DOI once the map is validated.

Data

No dataset and no data link were found in the paper.

Data availability

Relevant source data are provided within this paper. RNA-sequencing data is available on NCBI Gene Expression Omnibus (GEO) and are available under GEO Series accession GSE297948. The reference resources used in this study include the Genome Reference Consortium Human Build 38 (GRCh38) assembly. See “Source Data” for data series. Source data are provided with this paper.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 30 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 12 authors, 2 keywords, 11 MeSH terms, 1 funder, 62 references.

Cite

This paper

Golinski, S. R., Soriano, K., Briegel, A. C., Burke, M. C., Tang, S., Carvill, G. L., Sherrill, E., Lentucci, C., Yu, T. W., Nakayama, T., Hu, R., & Smith, R. S. (2026). RNA targeting therapy for a prenatally enriched potassium channel associated with severe childhood epilepsy and premature death. Nature communications, 17(1), 5864. https://doi.org/10.1038/s41467-026-72334-7

BibTeX

@article{golinski2026rna,
author = {Golinski, Sean R. and Soriano, Karla and Briegel, Alex C. and Burke, Madeline C. and Tang, Sheng and Carvill, Gemma L. and Sherrill, Emma and Lentucci, Claudia and Yu, Timothy W. and Nakayama, Tojo and Hu, Ruilong and Smith, Richard S.},
title = {{RNA targeting therapy for a prenatally enriched potassium channel associated with severe childhood epilepsy and premature death}},
journal = {Nature communications},
year = {2026},
month = apr,
volume = {17},
number = {1},
pages = {5864},
publisher = {Nature Publishing Group},
issn = {2041-1723},
doi = {10.1038/s41467-026-72334-7},
url = {https://doi.org/10.1038/s41467-026-72334-7},
pmid = {42056090},
pmcid = {PMC13333874}
}

RIS

TY - JOUR
AU - Golinski, Sean R.
AU - Soriano, Karla
AU - Briegel, Alex C.
AU - Burke, Madeline C.
AU - Tang, Sheng
AU - Carvill, Gemma L.
AU - Sherrill, Emma
AU - Lentucci, Claudia
AU - Yu, Timothy W.
AU - Nakayama, Tojo
AU - Hu, Ruilong
AU - Smith, Richard S.
TI - RNA targeting therapy for a prenatally enriched potassium channel associated with severe childhood epilepsy and premature death
T2 - Nature communications
J2 - Nat Commun
PY - 2026
DA - 2026/04/29
VL - 17
IS - 1
SP - 5864
SN - 2041-1723
PB - Nature Publishing Group
DO - 10.1038/s41467-026-72334-7
UR - https://doi.org/10.1038/s41467-026-72334-7
LA - en
ER -

CSL-JSON

{
"id": "10.1038/s41467-026-72334-7",
"type": "article-journal",
"title": "RNA targeting therapy for a prenatally enriched potassium channel associated with severe childhood epilepsy and premature death",
"container-title": "Nature communications",
"author": [
{
"family": "Golinski",
"given": "Sean R."
},
{
"family": "Soriano",
"given": "Karla"
},
{
"family": "Briegel",
"given": "Alex C."
},
{
"family": "Burke",
"given": "Madeline C."
},
{
"family": "Tang",
"given": "Sheng"
},
{
"family": "Carvill",
"given": "Gemma L."
},
{
"family": "Sherrill",
"given": "Emma"
},
{
"family": "Lentucci",
"given": "Claudia"
},
{
"family": "Yu",
"given": "Timothy W."
},
{
"family": "Nakayama",
"given": "Tojo"
},
{
"family": "Hu",
"given": "Ruilong"
},
{
"family": "Smith",
"given": "Richard S."
}
],
"container-title-short": "Nat Commun",
"volume": "17",
"issue": "1",
"page": "5864",
"DOI": "10.1038/s41467-026-72334-7",
"PMID": "42056090",
"PMCID": "PMC13333874",
"ISSN": "2041-1723",
"publisher": "Nature Publishing Group",
"URL": "https://doi.org/10.1038/s41467-026-72334-7",
"language": "en",
"issued": {
"date-parts": [
[
2026,
4,
29
]
]
}
}

The tracing map gets a citation of its own once an author has validated it and it has a DOI.

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1038/s41591-026-04314-9
Antisense oligonucleotide-mediated knockdown therapy in two infants with severe KCNT1 epileptic encephalopathy.
Journal: Nature medicine
In common: epilepsy, 17 references, 2 authors
[2] doi:10.1016/j.celrep.2024.113904
Disease-causing Slack potassium channel mutations produce opposite effects on excitability of excitatory and inhibitory neurons.
Journal: Cell reports
In common: epilepsy, 7 references
[3] doi:10.1126/sciadv.adv3140 [code]
Neuronal potassium channel activity triggers initiation of mRNA translation through binding of translation regulators.
Journal: Science advances
In common: 5 references
[4] doi:10.3389/fncel.2024.1367838
Case report: Marked electroclinical improvement by fluoxetine treatment in a patient with <i>KCNT1</i>-related drug-resistant focal epilepsy.
Journal: Frontiers in cellular neuroscience
In common: epilepsy, 4 references
[5] doi:10.1016/j.omtn.2025.102815 [code]
Atrophin-1 antisense oligonucleotide provides robust protection from pathology in a fully humanized DRPLA model.
Journal: Molecular therapy. Nucleic acids
In common: 1 reference, author Timothy W. Yu
[6] doi:10.1016/j.devcel.2022.09.011
Loss of non-motor kinesin KIF26A causes congenital brain malformations via dysregulated neuronal migration and axonal growth as well as apoptosis.
Journal: Developmental cell
In common: 1 reference, author Richard S. Smith
[7] doi:10.1371/journal.pgen.1011962
A scaffold attachment factor PHM-2 regulates synaptic transmission through SLO-2 potassium channel in C. elegans.
Journal: PLoS genetics
In common: 4 references
[8] doi:10.1093/sleepadvances/zpaf009
Tonic-clonic seizures induce hypersomnia and suppress rapid eye movement sleep in mouse models of epilepsy.
Journal: Sleep advances : a journal of the Sleep Research Society
In common: epilepsy, 3 references
[9] doi:10.1038/s41593-025-02096-w [code]
TDP-43-dependent mis-splicing of KCNQ2 triggers intrinsic neuronal hyperexcitability in ALS/FTD.
Journal: Nature neuroscience
In common: 4 references
[10] doi:10.1038/s41467-024-52443-x [code]
Conserved transcriptional regulation by BRN1 and BRN2 in neocortical progenitors drives mammalian neural specification and neocortical expansion.
Journal: Nature communications
In common: author Richard S. Smith

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Add the badge to the code's README

OSCR: the badge of this paper

If you are an author or a maintainer of this paper's code, you can add this badge. It says what OSCR knows of the paper (its code, its validated tracing map) and links the code to this page. Paste one of these snippets under the README's title. Keep the two marks around it, so that the badge can be replaced in place and is never added twice. OSCR changes nothing in your repository.

Markdown
<!-- oscr-badge:start -->
[![OSCR](https://openscicode.org/badge/doi/10.1038/s41467-026-72334-7.svg)](https://openscicode.org/badge/doi/10.1038/s41467-026-72334-7)
<!-- oscr-badge:end -->
reStructuredText
.. oscr-badge:start

.. image:: https://openscicode.org/badge/doi/10.1038/s41467-026-72334-7.svg
   :target: https://openscicode.org/badge/doi/10.1038/s41467-026-72334-7
   :alt: OSCR

.. oscr-badge:end
HTML
<!-- oscr-badge:start -->
<a href="https://openscicode.org/badge/doi/10.1038/s41467-026-72334-7"><img src="https://openscicode.org/badge/doi/10.1038/s41467-026-72334-7.svg" alt="OSCR"></a>
<!-- oscr-badge:end -->

If you choose to, you can have the badge kept up to date for you, with oscr badge --write from the command line or with the GitHub Action in your repository's workflows. Every other form and option (a card, AsciiDoc, LaTeX, shields.io) is on the badge page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Report a mismatch between the code and the paper · Report a code error (signed in)

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Report a reproduction failure (signed in)

Versions of its code: the releases of its code tied to a version of this paper (the preprint, the accepted manuscript, the version of record…), each with the tracing map versioned with it.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.